Open user controls
- Log In Using Your Account
  Log In
  
  Don't have an account? Sign Up Today

- My Account
- Dashboard
- Profile
- Saved items
- Logout

48°
- Benton, AR (72018)
  Today
  
  Cloudy with occasional light rain...mainly in the morning. High 59F. Winds ENE at 5 to 10 mph. Chance of rain 70%..
  
  Tonight
  
  Cloudy. Low 42F. Winds NE at 5 to 10 mph.
  
  Updated: January 2, 2026 @ 8:28 am
- Full Forecast

- Site search

Home
News
- Local News
Sports
Obituaries
Multimedia
- Photo Galleries
- Videos
e-Edition
Classifieds
Archives
Readers Choice 2025

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

16.42 +0.18 (+1.11%)

Streaming Delayed Price Updated: 10:06 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Year-End Biotech Chill: Adaptive Biotechnologies Braces for J.P. Morgan Crucible Amid Market Sell-Off

December 30, 2025

As the final trading days of 2025 wind down, the biotechnology sector finds itself caught in a paradoxical "bifurcated" squeeze. While the broader indices have touched record highs this year, a sharp...

Via MarketMinute

Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

December 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Earnings Scheduled For November 5, 2025 ↗

November 05, 2025

Via Benzinga

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease

December 09, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

December 06, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

November 24, 2025

Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug development

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

November 06, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Reports Third Quarter 2025 Financial Results

November 05, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood Goes All-In On Peter Thiel's Crypto Play Bullish With Back-To-Back Million-Dollar Buys ↗

November 04, 2025

Cathie Wood-led Ark Invest purchased shares in Bullish, a crypto exchange backed by Peter Thiel, through three of its funds. Other key trades were also made, including buying shares in CRISPR and Beam...

Via Benzinga

Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025

October 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday ↗

October 13, 2025

Via Benzinga

A Glimpse Into The Expert Outlook On Adaptive Biotechnologies Through 4 Analysts ↗

September 30, 2025

Via Benzinga

United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday ↗

September 30, 2025

Via Benzinga

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

August 27, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum ↗

August 09, 2025

Adaptive Biotechnologies (ADPT) aligns with Minervini's trend and high-growth momentum strategies, showing strong technicals, rising earnings, and revenue growth. A top pick for trend investors.

Via Chartmill

Why Adaptive Biotechnologies Stock Popped by Almost 6% on Wednesday ↗

August 06, 2025

One of the company's businesses is particularly hot at the moment.

Via The Motley Fool

Adaptive (ADPT) Q2 Revenue Surges 36% ↗

August 06, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 05, 2025

Via Benzinga

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results

August 05, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics ↗

July 26, 2025

Ark Invest traded in VCYT, IRDM, CRSP, KTOS, ABSI, VEEV, ADPT, and GH. Mainly focused on healthcare innovation.

Via Benzinga

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

July 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies and Flatiron Health Announce Integration of clonoSEQ® MRD Testing into OncoEMR®

July 01, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood's Ark Invest Adds Airbnb, AMD, Shopify To Portfolio, Slashes Stake In Circle Internet ↗

June 21, 2025

Via Benzinga

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts ↗

June 18, 2025

Via Benzinga

ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A High-Growth Stock Meeting Minervini’s Trend Template ↗

June 14, 2025

ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a compelling candidate for momentum investors.

Via Chartmill

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration ↗

May 30, 2025

Ark Invest made significant trades in TSLA, TXG, NTLA, DDD, and ADPT. Purchase of TXG and NTLA from ARKG and ARKK funds, and sale of TSLA, DDD, and ADPT from various funds.

Via Benzinga

Topics Government

Adaptive Biotechnologies Highlights New Data at 2025 ASCO Annual Meeting and EHA 2025 Congress Demonstrating How clonoSEQ® MRD Assessment is Optimizing Patient Care and Drug Development in Lymphoid Cancers

May 30, 2025

30 scientific abstracts will be presented using clonoSEQ for MRD assessment across multiple types of blood cancers

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
Local Events
Obituaries
Multimedia
Announcements
e-Edition
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

bentoncourier.com
321 North Market Street
Benton, AR 72018
Phone: 501-315-8228
Email: bcadmin@bentoncourier.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Log In Using Your Account

Benton, AR (72018)

Today

Tonight

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

All News about Adaptive Biotechnologies Corporation - Common Stock

Sections

Services

Follow Us